FDA Purple Book — Biologics & Biosimilars Search

Search the latest monthly FDA Purple Book download for licensed biological products, including reference products, biosimilars, and interchangeable biosimilars.

Independent tool. Not affiliated with or endorsed by the U.S. Food and Drug Administration (FDA).

Why use it

The Purple Book is a core FDA source for biologic-product competition and regulatory research. This Actor converts the current monthly download into automation-friendly rows with filters for product names, applicants, BLA numbers, license type, and marketing status.

Useful for biosimilar/reference-product landscape research, regulatory and business-development monitoring, biologics competitive intelligence, BLA/applicant lookups, and repeatable data pipelines.

Common use cases

• Research biosimilar and reference-product landscapes
• Look up products by name, applicant, or BLA number
• Filter current biologics by license type or marketing status
• Build repeatable regulatory and business-development data pipelines

Try it

{"query":"adalimumab","maxRows":25}

Output

Each result includes normalized FDA fields, untouched non-empty source columns under raw, source release month, source freshness metadata, and capture time.

Source behavior

The Actor first reads FDA's Purple Book downloads page, discovers the newest monthly CSV, and parses the full-database section rather than returning only that month's changes.

Pricing

Private candidate pricing: $0.001 per returned product row ($1 per 1,000). Only returned product rows are billable.

Official source

https://purplebooksearch.fda.gov/index.cfm?event=downloads

Important limitations

This is a research/data-access utility, not legal, medical, patent, interchangeability, exclusivity, or regulatory advice. Verify material decisions against the current FDA product record.

About Piven Core

Built and maintained by Piven Core — focused data APIs and automation utilities for reliable, production-ready workflows.

Learn more: https://pivencore.com